DPIC NOTE CHANNEL
رفتن به کانال در Telegram
1 594
مشترکین
اطلاعاتی وجود ندارد24 ساعت
+17 روز
+330 روز
آرشیو پست ها
1 594
Repost from Pulmonology pearls
Review Article
Nebulized Heparin in Adults With Acute Respiratory Failure: A Meta-Analysis of Randomized Trials
the Nebulized Heparin Study Group
Critical Care Medicine 54(7):p 1755-1766, July 2026. | DOI: 10.1097/CCM.0000000000007161
1 594
Repost from Pulmonology pearls
American Journal of Kidney Diseases
Available online 3 July 2026
In Press, Journal Pre-proof
Perspective
Approach to Hyperkalemia: The Role of Diet and Pharmacological Therapies
https://doi.org/10.1053/j.ajkd.2026.03.048
1 594
Repost from Pulmonology pearls
Feature Article
Inhaled Antibiotics to Treat Ventilator-Associated Pneumonia: A Systematic Review and Meta-Analysis
Critical Care Medicine 54(6):p 1293-1308, June 2026. | DOI: 10.1097/CCM.0000000000007072
1 594
Repost from Pulmonology pearls
The Lancet Respiratory Medicine
Available online 5 June 2026
In Press, Corrected Proof
Position Paper
Rheumatoid arthritis-associated interstitial lung disease: screening, diagnosis, and treatment—an expert group consensus statement
https://doi.org/10.1016/S2213-2600(26)00094-9
1 594
Repost from Pulmonology pearls
creager_et_al_2026_2026_aha_acc_accp_acep_chest_sc_260219_225656.pdf15.12 MB
1 594
Repost from Pulmonology pearls
The Lancet Respiratory Medicine
Available online 12 February 2026
In Press, Corrected Proof
Articles
Budesonide–glycopyrronium–formoterol fumarate dihydrate in uncontrolled asthma (KALOS and LOGOS): twin multicentre, double-blind, double-dummy, parallel-group, randomised, phase 3 trials
KALOS and LOGOS study investigators †
https://doi.org/10.1016/S2213-2600(25)00457-6
1 594
Edit, Sign and Share PDF files on the go. Download the Acrobat Reader app: https://adobeacrobat.app.link/Mhhs4GmNsxb
1 594
Repost from Quality professional - Alaa Abdrabouh
Total Quality Management and Operational Excellence
@QualityProfessionals
1 594
ich-guideline-m13b-bioequivalence-immediate-release-solid-oral-dosage-forms-additional-strengths-step-2b_en.pdf
